Sangiorgi Luca, MD
Director of the Department: Rare Skeletal Diseases, Rizzoli Orthopaedic Institute
Medical degree at the University of Bologna (Italy) in 1988.
PhD in Clinical Genetics at “La Sapienza” University in Rome.
Board in Oncology at University of Bologna.
- From 1991 to 1993: Oncologist at the Laboratory of Oncology Research, “Codivilla Putti” Research Center Rizzoli Orthopaedic Institute.
- From 1994 to 1996: Visiting Scientist at the Molecular Oncology Section, Pediatric Branch, National Cancer Institute, National Institute of Health, Bethesda, Maryland.
- From 1996 to 2001: Senior Scientist, Laboratory of Oncology Research, "Codivilla-Putti" Research Center, Rizzoli Orthopaedic Institute.
- From 2001 to 06/2008: Head, Medical Genetic Unit, Rizzoli Orthopaedic Institute
- From June 2008 – Present: Head, Medical Genetic Department, Rizzoli Orthopaedic Institute.
English: Full Professional Proficiency.
Good competence on most common operating systems and most common internet browser.
Contract professor of Clinical Genetics for the Medical School and of Clinical Bioinformatics for the Faculty of Science, Mathematics and Physics of the University of Bologna.
Coordinator for Emilia Romagna region (Health Social and welfare Regional Agency) of the commitment EIP-AHA Action Plan 1 "Adherence to prescription, treatment and therapy".
In 2013 he was nomineed as Italian government representant by the Ministry of Health for BBMRI Italy in Europe about Biobank and clinical data repositories.
Coordinator of the Rizzoli Rare Disease Center and responsible of 3 National Registers of Rare Disease (Li-Fraumeni Syndrome, Multiple Hereditary Exostoses and Osteogenesis Imperfecta).
Member of the National Coordination Team for Clinical Genetics Departments and coordinates the National and Regional Hub and Spoke Network on Skeletal Dysplasias.
Coordinator of many the Regional Lab for Bioinformatics (CLIBI, BioPharmaNet, Piattaforma Scienza della Vita, GeBBA-Lab) he is also member of HL7 interest group for bioinformatics.
Contributor of more than 50 articles published in peer reviewed journal such as American Journal of Human Genetics, Journal of Clinical Oncology, Human Mutation and International Journal of Cancer.
Active member of several international medical association and serving in the Executive Committee of the CTOS as President.
Expert Reviewer for the European Union Commission for the Framework Projects 6 (FP6) and Framework Projects 7 (FP7) grants.
Clinical Bioinformatics, Molecular Genetics and Correlation between genotype and phenotype in musculoskeletal genetic disorders and bone sarcomas